Two Sigma Advisers’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,878,000	Closed	-$16.7M	–	8
2025 Q4	$16.7M	Buy	4,878,000 +78,100	+2%	+$349K	0.03%	396
2025 Q3	$24.1M	Buy	4,799,900 +729,600	+18%	+$3.22M	0.05%	280
2025 Q2	$14M	Buy	4,070,300 +1,425,500	+54%	+$3.55M	0.03%	421
2025 Q1	$5.9M	Buy	2,644,800 +36,400	+1%	+$104K	0.01%	720
2024 Q4	$7.64M	Buy	2,608,400 +430,800	+20%	+$1.2M	0.02%	559
2024 Q3	$5.66M	Buy	2,177,600 +412,800	+23%	+$1.14M	0.01%	669
2024 Q2	$5.22M	Buy	1,764,800 +7,200	+0.4%	+$27.2K	0.01%	740
2024 Q1	$7.96M	Buy	1,757,600 +764,300	+77%	+$3.9M	0.02%	607
2023 Q4	$5.67M	Buy	993,300 +290,400	+41%	+$1.35M	0.01%	749
2023 Q3	$3.23M	Buy	702,900 +112,600	+19%	+$685K	0.01%	938
2023 Q2	$3.81M	Buy	590,300 +49,900	+9%	+$341K	0.01%	880
2023 Q1	$4.07M	Sell	540,400 -88,400	-14%	-$803K	0.01%	897
2022 Q4	$6.37M	Buy	628,800 +161,100	+34%	+$1.86M	0.02%	680
2022 Q3	$4.63M	Buy	467,700 +420,400	+889%	+$4.61M	0.01%	771
2022 Q2	$504K	Buy	47,300 +22,900	+94%	+$194K	﹤0.01%	1919
2022 Q1	$238K	Buy	+24,400	New	+$231K	﹤0.01%	2327
2021 Q2	–	Sell	-20,800	Closed	-$706K	–	2419
2021 Q1	$706K	Buy	+20,800	New	+$829K	﹤0.01%	1845